Skip to content
Parakho

Gujarat Fluorochemicals LtdQ4 FY26 earnings call

All quarters

Summary generated by AI from the official transcript Gujarat Fluorochemicals Ltd filed with BSE on 01 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries

The short read

Gujarat Fluorochemicals reported Q4 FY26 chemicals segment revenue growth of 11% year-on-year to Rs 1,358 crores, with EBITDA up 13% to Rs 353 crores and PAT up 5% to Rs 169 crores, led by the Fluoropolymers segment and the start of R-32 production in March 2026. Management outlined FY27 capex plans of Rs 3,150 crores, split between Rs 2,300 crores for GFCL EV Products and Rs 850 crores for GFL chemicals businesses. Battery materials remained loss-making in the quarter due to costs flowing through the P&L after the LiPF6 plant capitalization in January, though management said commercial sales of LiPF6 salt have begun ramping up with contracted volumes for FY27.

Numbers mentioned

Chemicals segment revenue: Rs 1,358 crores (Q4 FY26)

p. 3
our chemicals business delivered a commendable performance during Q4 with revenue growing 11% year-on-year to INR1,358 crores

Bir Kapoor, page 3 of the filed PDF · View the filing

Chemicals segment EBITDA: Rs 353 crores (Q4 FY26)

p. 3
EBITDA increasing 13% year-on-year to INR353 crores

Bir Kapoor, page 3 of the filed PDF · View the filing

Chemicals segment PAT: Rs 169 crores (Q4 FY26)

p. 3
PAT rising 5% year-on-year to INR169 crores as compared to Q4 FY '25

Bir Kapoor, page 3 of the filed PDF · View the filing

Fluoropolymers segment revenue: Rs 848 crores (Q4 FY26)

p. 4
The Fluoropolymers segment delivered a strong performance with revenues growing 19% year-on-year and 14% quarter-on-quarter to INR848 crores in Q4 FY '26

Bir Kapoor, page 4 of the filed PDF · View the filing

FY27 total capex: Rs 3,150 crores (FY27)

p. 3
GFL has earmarked INR3,150 crores of capex for FY '27, of which INR2,300 is for GFCL EV and INR850 crores for GFL

Bir Kapoor, page 3 of the filed PDF · View the filing

R-32 capacity commissioned: over 10,000 tons

p. 6
we have achieved over 10,000 ton capacity at the moment

Bir Kapoor, page 6 of the filed PDF · View the filing

EV business capex invested to date: approximately INR1,900 crores to INR2,000 crores

p. 12
approximately INR1,900 crores to INR2,000 crores is what we have already invested so far, Tejas

Bir Kapoor, page 12 of the filed PDF · View the filing

What management said it would do

A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.

Refrigerant gas (R-32) capacity — 20,000 tons

stated firmly by Bir Kapoor

p. 6
we have announced that we'll be going up to 20,000 tons in R-32

Bir Kapoor, page 6 of the filed PDF · View the filing

Fluoropolymers segment growth — 15% to 20% · this year

stated firmly by Kapil Malhotra

p. 9
this year, we expect to see a growth of around 15% to 20% as compared to the last year in our fluoropolymers products

Kapil Malhotra, page 9 of the filed PDF · View the filing

Battery materials cumulative capex — INR6,000 crores · by FY28

stated firmly by Bir Kapoor

p. 5
we remain committed to our previously outlined guidelines of INR6,000 crores cumulative capex by FY '28 across the battery materials portfolio

Bir Kapoor, page 5 of the filed PDF · View the filing

Battery materials asset turns — nearly 2x

stated as an aspiration by Bir Kapoor

p. 5
with targeted asset turns of nearly 2x and EBITDA margins of over 25% plus

Bir Kapoor, page 5 of the filed PDF · View the filing

Battery materials earnings potential — FY29

stated as an aspiration by Bir Kapoor

p. 5
The full earnings potential of these investments is expected to be realized by FY '29 as the facilities progressively ramp up and achieve an optimum utilization level

Bir Kapoor, page 5 of the filed PDF · View the filing

Cathode active material qualification — end of Q3

stated firmly by Bir Kapoor

p. 5
final qualification is expected by the end of the third quarter

Bir Kapoor, page 5 of the filed PDF · View the filing

Refrigerant gas capex — INR150 crores · current financial year

stated firmly by Bir Kapoor

p. 4
We will be incurring INR150 crores of capex on increasing capacities of refrigerant gases in the current financial year

Bir Kapoor, page 4 of the filed PDF · View the filing

Battery chemicals revenue run-rate — 3-digit number · by end of FY27

stated firmly by Bir Kapoor

p. 15
we expect to reach, of course, the 3-digit number by the end of this quarter -- by the end of this financial year in the last quarter, yes

Bir Kapoor, page 15 of the filed PDF · View the filing

Q&A highlights

Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.

Management said the new investment is in new fluoropolymers, and did not break out growth by product but noted existing capacities are nearing optimum utilization.

Answered by Bir Kapoor

Asked by Ankur Periwal: Whether the fluoropolymer capex expansion is for PTFE or new fluoropolymers, and how growth breaks down between them.

p. 6
the investment will be on new fluoropolymers. And so far, we have not been giving any breakup of growth of respective fluoropolymers

Bir Kapoor, page 6 of the filed PDF · View the filing

Management explained that after plant capitalization, preoperative expense capitalization stops and all costs flow through the P&L, plus a one-time forex loss on buyer's credit.

Answered by Manoj Agrawal

Asked by Sanjesh Jain: Why battery segment EBITDA losses jumped sharply this quarter despite flat revenues.

p. 8
Once we start the operations, the accounting standard doesn't allow you to capitalize the expenses.

Manoj Agrawal, page 8 of the filed PDF · View the filing

Management confirmed a price increase was taken while maintaining EBITDA margins despite rising raw material and logistics costs.

Answered by Bir Kapoor

Asked by Sanjesh Jain: Whether fluoropolymer price increases taken by competitors have also been taken by GFCL.

p. 9
There has been a price increase. We have also taken a price increase

Bir Kapoor, page 9 of the filed PDF · View the filing

Management said performance is in line with earlier indicated EBITDA margins and there is no disconnect with expectations.

Answered by Bir Kapoor

Asked by Arun Prasath: Whether current fluoropolymer EBITDA is the steady-state level envisaged when plants were built two years ago.

p. 10
this has been in line with what we had thought because we had already given an indication of certain EBITDA margins and which we have been sustaining

Bir Kapoor, page 10 of the filed PDF · View the filing

Management said there is no impact on the Oman project and capex plans remain unchanged.

Answered by Bir Kapoor

Asked by Tejas Sonawane: Status of the Oman capex project given Middle East developments.

p. 12
We will go ahead with the capex, There are no impacts on Oman, if you look at the overall capacity.

Bir Kapoor, page 12 of the filed PDF · View the filing

Management attributed the change to a high prior-year base effect from exceptional chemical prices and to warehouse stocking requirements, expecting improvement as turnover grows.

Answered by Manoj Agrawal

Asked by Darshita Shah: Why inventory days have risen and how working capital will evolve as the battery business scales.

p. 13
our average working capital cycle remains high. Further, we are now stabilizing and building up our EV business.

Manoj Agrawal, page 13 of the filed PDF · View the filing

Management said the plant has been operating at optimal capacity since April, serving both domestic and export markets with some contracts in place.

Answered by Bir Kapoor

Asked by Rohit Nagraj: Whether R-32 is already operating at optimal levels and what the customer mix looks like.

p. 14
It's already started operating from April onwards. So it's already operating at the optimal capacities.

Bir Kapoor, page 14 of the filed PDF · View the filing

Risks flagged

Volatile global operating environment from US tariff policy and geopolitical tensions disrupting trade, logistics and commodity/currency markets

p. 3
FY '26 was marked by a highly volatile global operating environment.

Bir Kapoor, page 3 of the filed PDF · View the filing

Higher input and logistics costs from sharp energy price movements

p. 3
Sharp movement in energy prices have also resulted in higher input and logistic costs across businesses.

Bir Kapoor, page 3 of the filed PDF · View the filing

Weakness in the Middle East refrigerant market

p. 4
despite weakness in the Middle East market in the month of March and an overall challenging global environment, this segment delivered a stable performance

Bir Kapoor, page 4 of the filed PDF · View the filing

Caustic soda pricing pressure from domestic capacity additions

p. 4
pricing is likely to remain range-bound due to domestic capacity additions and balanced supply/demand dynamics

Bir Kapoor, page 4 of the filed PDF · View the filing

Fluoromethane business facing range-bound performance amid moderate demand and competition

p. 4
the performance in fluoromethane business is expected to remain range-bound in the near term amid moderate demand conditions and competitive market dynamics

Bir Kapoor, page 4 of the filed PDF · View the filing

Onetime forex loss from buyer's credit due to extreme dollar-INR movement amid Iran-US conflict

p. 8
the movement of dollar and INR was extreme due to Iran and U.S. war

Manoj Agrawal, page 8 of the filed PDF · View the filing

Increased voyage transit times due to geopolitical situation requiring higher inventory

p. 14
the voyage time has increased from almost 3 to 4 weeks to almost 7 to 8 weeks

Kapil Malhotra, page 14 of the filed PDF · View the filing

Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.